Clinical Trial Update: Intravenous Paricalcitol in Chronic Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for intravenous paricalcitol in chronic hemodialysis patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: The University of Hong Kong | Conditions: Endstage Renal Disease, Secondary Hyperparathyroidism | Phase 4 | Status: UNKNOWN